Brief: vTv Therapeutics Announces 2022 First Quarter Financial Results
12/05/2022 12:47
May 12 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES 2022 FIRST QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* VTV THERAPEUTICS INC - COMPANY'S CASH POSITION AS OF MARCH
31,
2022, WAS $12.1 MILLION COMPARED TO $13.4 MILLION AS OF DECEMBER
31, 2021
* VTV THERAPEUTICS INC - DILUTED NET LOSS PER SHARE WAS
$0.10 FOR
THREE MONTHS ENDED MARCH 31, 2022
Source text for Eikon: ID:nGNX35dxN0
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)